| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 50 |
| 1 | ASPIRIN | 48 |
| 2 | ASPIRIN 325 MG | 46 |
| 3 | ASPIRIN 81 MG | 46 |
| 4 | PREDNISONE | 42 |
| 5 | ACETAMINOPHEN | 37 |
| 6 | OMEPRAZOLE MAGNESIUM | 35 |
| 7 | FINGOLIMOD HCL | 31 |
| 8 | LORAZEPAM | 31 |
| 9 | ERGOCALCIFEROL | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPARSENTAN | 9 | 0.0013 |
| 1 | CALCIUM ACETATE | 7 | 0.0013 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 3 | TOLVAPTAN | 16 | 0.0011 |
| 4 | ERGOCALCIFEROL | 30 | 0.0010 |
| 5 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 12 | 0.0010 |
| 6 | POLATUZUMAB VEDOTIN | 10 | 0.0010 |
| 7 | ASFOTASE ALFA | 10 | 0.0010 |
| 8 | RIBOCICLIB | 26 | 0.0008 |
| 9 | ENTECAVIR | 7 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 103 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 101 |
| 2 | Benzodiazepine [EPC] | 68 |
| 3 | Loop Diuretic [EPC] | 58 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 48 |
| 5 | Osmotic Laxative [EPC] | 45 |
| 6 | Proton Pump Inhibitor [EPC] | 45 |
| 7 | Atypical Antipsychotic [EPC] | 39 |
| 8 | Kinase Inhibitor [EPC] | 38 |
| 9 | Vitamin C [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 6 | 0.0026 |
| 1 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 2 | 0.0022 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 3 | Antihypoglycemic Agent [EPC] | 6 | 0.0014 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 16 | 0.0011 |
| 5 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 10 | 0.0010 |
| 7 | Neurokinin 3 Receptor Antagonist [EPC] | 2 | 0.0009 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |